CytoSorbents Regains Compliance, Continues on Nasdaq
Company Announcements

CytoSorbents Regains Compliance, Continues on Nasdaq

Cytosorbents (CTSO) has issued an update.

CytoSorbents Corporation has successfully met Nasdaq’s minimum bid price requirement, ensuring its continued listing on the market. The company’s stock maintained a closing price of at least $1.00 for over ten consecutive days, rectifying the previous non-compliance issue where the stock had fallen below this threshold. With this achievement, CytoSorbents has received official confirmation from Nasdaq that it has regained compliance, and the matter is now considered closed.

For a thorough assessment of CTSO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCytoSorbents Corporation’s Q3 2024 Financial Highlights
TheFlyCytoSorbents reports Q3 adjusted EPS (8c), consensus (6c)
Ryan AdistIs CTSO a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App